RUNX2 and Hepatic fibrosis: Notably, as blocking αv integrins could not fully rescue Runx2 overexpression accelerating liver fibrosis, we could not exclude the possibility that other downstream targets are involved in Runx2‐mediated HSC activation and liver fibrosis.